Cargando…
Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases
Rare diseases pose a global challenge, in that their collective impact on health systems is considerable, whereas their individually rare occurrence impedes research and development of efficient therapies. In consequence, patients and their families are often unable to find an expert for their affli...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469594/ https://www.ncbi.nlm.nih.gov/pubmed/30945166 http://dx.doi.org/10.1007/s40291-019-00392-3 |